Publications

Evidence of our team's scientific rigour and commitment to medical advancement can be found in our extensive library of Niche Publications. We believe that sharing the results of our collaborative research is essential for fostering innovation and improving patient outcomes.

This resource brings together our peer reviewed papers, conference presentations, and technical posters, showcasing our deep expertise across a broad range of therapeutic areas from cardiovascular endocrinology to complex frailty studies. By making our published work accessible, we aim to contribute to the global scientific dialogue and provide our partners with a transparent look at the high standard clinical and analytical thinking that underpins every Niche project.

Explore our bibliography to see how we are helping to shape the future of medicine.

Acknowledged Publications

Recognised contributions to world-class research

A selection of peer-reviewed publications where Niche's scientific and clinical expertise has been formally acknowledged by research teams worldwide, reflecting the breadth and depth of our contribution to advancing medical knowledge.

Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease

Written by

Taylor PC, Askari A, Choy E, Ehrenstein MR, Else S, Nisar MK.

Explore The Publication

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Written by

Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators.

Explore The Publication

« Previous 1 2 3 4 … 58 Next »

Niche Manuscripts

Where our words shape the science

Publications where the Niche medical writing team played a central role in crafting the manuscript itself — translating complex clinical data into clear, compelling and submission-ready scientific communications.

Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control

Written by

Zeng X, Qing J, Li CM, Lu J, Yamawaki T, Hsu YH, Vander Lugt B, Hsu H, Busby J, McDowell PJ, Jackson DJ, Djukanovic R, Matthews JG, Arron JR, Bradding P, Brightling CE, Chaudhuri R, Choy DF, Cowan D, Fowler SJ, Hardman TC, Harrison T, Howarth P, Lordan J, Mansur AH, Menzies-Gow A, Pavord ID, Walker S, Woodcock A, Heaney LG; investigators for the UK MRC Refractory Asthma Stratification Program (RASP-UK).

Explore The Publication

A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex

Written by

Eastwood MC, Busby J, Jackson DJ, Pavord ID, Hanratty CE, Djukanovic R, Woodcock A, Walker S, Hardman TC, Arron JR, Choy DF, Bradding P, Brightling CE, Chaudhuri R, Cowan D, Mansur AH, Fowler SJ, Howarth P, Lordan J, Menzies-Gow A, Harrison T, Robinson DS, Holweg CTJ, Matthews JG, Heaney LG; Refractory Asthma Stratification Programme (UK) Investigators.

Explore The Publication

« Previous 1 2 3 4 … 47 Next »

Publications

Acknowledged Publications

Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Niche Manuscripts

Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control

A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex

Hi ✋